Can Nuvation Bio Inc (NUVB) Stock Soar 150% From Current Level?

Nuvation Bio Inc (NYSE:NUVB) is one of billionaire David Abrams’ top stock picks with upside potential. Nuvation Bio shares gained nearly 170% over the past year, and analysts project a more than 150% upside for the stock over the next 12 months. Some 41 hedge funds are backing Nuvation Bio stock.

This comes as Nuvation Bio Inc (NYSE:NUVB) works to expand the market for its lung cancer drug. On June 29, Nuvation Bio said that the UK drug regulator had accepted the marketing application for its lung cancer drug and would review the request to decide whether to approve or reject it. The marketing application was submitted by Nuvation Bio’s partner Eisai.

The drug, known as taletrectinib, targets advanced ROS1-positive non-small cell lung cancer. Nuvation Bio has already secured marketing approvals for the drug in the US, Japan, and China. It is seeking the drug’s approval in the UK and other international markets.

In the meantime, Nuvation Bio is shoring up its balance sheet. The company exited Q1 2026 with $533.7 million in ash, cash equivalents, and marketable securities and recently raised $287.5 million through a notes offering.

Nuvation Bio Inc (NYSE:NUVB) is a global biopharmaceutical company focused on developing targeted therapies for cancers. The company aims to address unmet needs in cancer treatment. Its pipeline includes drug candidates targeting lung cancer and gliomas.

While we acknowledge the risk and potential of NUVB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NUVB and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: Seth Klarman Stock Portfolio: 10 Best Stocks to Top 10 Mid Cap Stocks to Own for Decades According to Hedge Funds.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1